/Vertex%20Pharmaceuticals%2C%20Inc_%20HQ%20in%20Boston-by%20Tada%20Images%20via%20Shuttershock.jpg)
Vertex Pharmaceuticals Incorporated (VRTX), based in Boston, Massachusetts, is a prominent biotech firm specializing in the discovery, development, and commercialization of innovative small-molecule drugs targeting serious diseases. Its core focus includes genetic disorders such as cystic fibrosis (CF) and sickle cell disease.
The company operates globally with extensive R&D and commercial sites, driving advancements through substantial investment in research, a strong manufacturing base, and efficient worldwide distribution to deliver transformative therapies to patients. Vertex has a market capitalization of $109.65 billion, which classifies it as a “large-cap” stock.
